Dr. Marcus Webb's hospital just placed Carvexin on Tier 3. He's frustrated about PA requirements, cost-skeptical vs. a generic competitor, and loyal to a rival rep he's known for 5 years. Your goal: overcome these objections without abandoning the call.

Dr. Priya Anand sees 30+ patients daily and tolerates rep visits out of habit. She's a "reactor" prescriber — she switches based on patient requests or colleague recommendations, not rep calls alone. Your task: create a memorable, personalized engagement that gives her a real reason to think of Carvexin.

Dr. James Patel has heard that Carvexin might benefit inflammatory cardiomyopathy — a use that is not FDA-approved. He'll ask you directly. You must respond in a way that's legally compliant, medically responsible, and doesn't destroy the relationship. The AI coach will flag any compliance missteps.

Your district manager Sarah Kim is reviewing your Q2 call plan. She's noticed 60% of calls are concentrated on your top 3 prescribers with almost no activity on 12 mid-tier physicians. She'll challenge your strategy — defend it with data or revise your approach in real time.